An Algorithm for Generating Individualized Treatment Decision Trees and Random Forests

References

• Arakaki, R., Blevins, T., Wise, J., Liljenquist, D., Jiang, H., Jacobson, J., Martin, S., and Jackson, J. (2014), “Comparison of Insulin Lispro Protamine Suspension Versus Insulin Glargine Once Daily Added to Oral Antihyperglycaemic Medications and Exenatide in Type 2 Diabetes: A Prospective Randomized Open-Label Trial,” Diabetes, Obesity and Metabolism, 16, 510–518.
   PubMed Web of Science ®Google Scholar
• Bergenstal, R. M., Bailey, C. J., and Kendall, D. M. (2010), “Type 2 Diabetes: Assessing the Relative Risks and Benefits of Glucose-Lowering Medications,” The American Journal of Medicine, 123, 374–e9.
   PubMed Web of Science ®Google Scholar
• Breiman, L. (1996), “Bagging Predictors,” Machine Learning, 24, 123–140.
   Web of Science ®Google Scholar
• ——— (2001), “Random Forests,” Machine Learning, 45, 5–32.
   Web of Science ®Google Scholar
• Breiman, L., Friedman, J., Olshen, R., and Stone, C. (1984), Classification and Regression Trees. Boca Raton, FL: CRC Press.
   Google Scholar
• Buse, J. B., Wolffenbuttel, B. H., Herman, W. H., Shemonsky, N. K., Jiang, H. H., Fahrbach, J. L., Scism-Bacon, J. L., and Martin, S. A. (2009), “DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results,” Diabetes Care, 32, 1007–1013.
   PubMed Web of Science ®Google Scholar
• Cai, T., Tian, L., Wong, P. H., and Wei, L. (2011), “Analysis of Randomized Comparative Clinical Trial Data for Personalized Treatment Selections,” Biostatistics, 12, 270–282.
   PubMed Web of Science ®Google Scholar
• Cortes, C., and Vapnik, V. (1995), “Support-Vector Networks,” Machine Learning, 20, 273–297.
   Web of Science ®Google Scholar
• Cummings, J., Emre, M., Aarsland, D., Tekin, S., Dronamraju, N., and Lane, R. (2010), “Effects of Rivastigmine in Alzheimer’s Disease Patients With and Without Hallucinations,” Journal of Alzheimer’s Disease, 20, 301–311.
   PubMed Web of Science ®Google Scholar
• Diamant, M., Van Gaal, L., Guerci, B., Stranks, S., Han, J., Malloy, J., Boardman, M. K., and Trautmann, M. E. (2014), “Exenatide Once Weekly Versus Insulin Glargine for Type 2 Diabetes (DURATION-3): 3-Year Results of an Open-Label Randomised Trial,” The Lancet Diabetes & Endocrinology, 2, 464–473.
   PubMed Web of Science ®Google Scholar
• Doyle, P. (1973), “The Use of Automatic Interaction Detector and Similar Search Procedures,” Operational Research Quarterly, 24, 465–467.
   Google Scholar
• Dusseldorp, E., and Van Mechelen, I. (2014), “Qualitative Interaction Trees: A Tool to Identify Qualitative Treatment–Subgroup Interactions,” Statistics in Medicine, 33, 219–237.
   PubMed Web of Science ®Google Scholar
• Faries, D. E., Chen, Y., Lipkovich, I., Zagar, A., Liu, X., and Obenchain, R. L. (2013), “Local Control for Identifying Subgroups of Interest in Observational Research: Persistence of Treatment for Major Depressive Disorder,” International Journal of Methods in Psychiatric Research, 22, 185–194.
   PubMed Web of Science ®Google Scholar
• Forst, T., Guthrie, R., Goldenberg, R., Yee, J., Vijapurkar, U., Meininger, G., and Stein, P. (2014), “Efficacy and Safety of Canagliflozin Over 52 Weeks in Patients With Type 2 Diabetes on Background Metformin and Pioglitazone,” Diabetes, Obesity and Metabolism, 16, 467–477.
   PubMed Web of Science ®Google Scholar
• Foster, J. C., Taylor, J. M., and Ruberg, S. J. (2011), “Subgroup Identification From Randomized Clinical Trial Data,” Statistics in Medicine, 30, 2867–2880.
   PubMed Web of Science ®Google Scholar
• Friedman, J., Hastie, T., and Tibshirani, R. (2001), The Elements of Statistical Learning (vol. 1), Springer Series in Statistics, Berlin: Springer.
   Google Scholar
• Fu, H., Zhou, J., and Faries, D. E. (2016), “Estimating Optimal Treatment Regimes via Subgroup Identification in Randomized Control Trials and Observational Studies,” Statistics in Medicine, 35, 3285--3302.
   PubMed Web of Science ®Google Scholar
• Hamburg, M. A., and Collins, F. S. (2010), “The Path to Personalized Medicine,” New England Journal of Medicine, 363, 301–304.
   PubMed Web of Science ®Google Scholar
• Hayes, D. F., Thor, A. D., Dressler, L. G., Weaver, D., Edgerton, S., Cowan, D., Broadwater, G., Goldstein, L. J., Martino, S., Ingle, J. N., et al. (2007), “HER2 and Response to Paclitaxel in Node-Positive Breast Cancer,” New England Journal of Medicine, 357, 1496–1506.
   PubMed Web of Science ®Google Scholar
• Imai, K., and Strauss, A. (2010), “Estimation of Heterogeneous Treatment Effects From Randomized Experiments, With Application to the Optimal Planning of the Get-Out-the-Vote Campaign,” Political Analysis, mpq035.
   Web of Science ®Google Scholar
• Laber, E., and Zhao, Y. (2015), “Tree-Based Methods for Individualized Treatment Regimes,” Biometrika, 102, 501–514.
   PubMed Web of Science ®Google Scholar
• Lawson, D., Sherman, V., and Hollowell, J. (1998), “The General Practice Research Database. Scientific and Ethical Advisory Group,” QJM: An International Journal of Medicine, 91, 445–452.
   PubMedGoogle Scholar
• Liaw, A., and Wiener, M. (2002), “Classification and Regression by randomForest,” R News, 2, 18–22.
   Google Scholar
• Lipkovich, I., Dmitrienko, A., Denne, J., and Enas, G. (2011), “Subgroup Identification Based on Differential Effect Search—A Recursive Partitioning Method for Establishing Response to Treatment in Patient Subpopulations,” Statistics in Medicine, 30, 2601–2621.
   PubMed Web of Science ®Google Scholar
• Liu, Y., Wang, Y., and Zeng, D. (2015), DTRlearn: Learning Algorithms for Dynamic Treatment Regimes, R package version 1.2.
   Google Scholar
• Loh, W.-Y. (2002), “Regression Tress With Unbiased Variable Selection and Interaction Detection,” Statistica Sinica, 12, 361–386.
   Web of Science ®Google Scholar
• Ludwig, J. A., and Weinstein, J. N. (2005), “Biomarkers in Cancer Staging, Prognosis and Treatment Selection,” Nature Reviews Cancer, 5, 845–856.
   PubMed Web of Science ®Google Scholar
• Matsouaka, R. A., Li, J., and Cai, T. (2014), “Evaluating Marker-Guided Treatment Selection Strategies,” Biometrics, 70, 489–499.
   PubMed Web of Science ®Google Scholar
• Morgan, J. N., and Sonquist, J. A. (1963), “Problems in the Analysis of Survey Data, and a Proposal,” Journal of the American Statistical Association, 58, 415–434.
   Web of Science ®Google Scholar
• Nyenwe, E. A., Jerkins, T. W., Umpierrez, G. E., and Kitabchi, A. E. (2011), “Management of Type 2 Diabetes: Evolving Strategies for the Treatment of Patients With Type 2 Diabetes,” Metabolism, 60, 1–23.
   PubMed Web of Science ®Google Scholar
• Piquette-Miller, M., and Grant, D. (2007), “The Art and Science of Personalized Medicine,” Clinical Pharmacology & Therapeutics, 81, 311–315.
   PubMed Web of Science ®Google Scholar
• Qian, M., and Murphy, S. A. (2011), “Performance Guarantees for Individualized Treatment Rules,” Annals of Statistics, 39, 1180.
   PubMed Web of Science ®Google Scholar
• R Core Team (2017), R: A Language and Environment for Statistical Computing, Vienna, Austria: R Foundation for Statistical Computing.
   Google Scholar
• Rosenbaum, P. R., and Rubin, D. B. (1983), “The Central Role of the Propensity Score in Observational Studies for Causal Effects,” Biometrika, 70, 41–55.
   Web of Science ®Google Scholar
• Strobl, C., Malley, J., and Tutz, G. (2009), “An Introduction to Recursive Partitioning: Rationale, Application, and Characteristics of Classification and Regression Trees, Bagging, and Random Forests,” Psychological Methods, 14, 323.
   PubMed Web of Science ®Google Scholar
• Su, X., Kang, J., Fan, J., Levine, R. A., and Yan, X. (2012), “Facilitating Score and Causal Inference Trees for Large Observational Studies,” Journal of Machine Learning Research, 13, 2955–2994.
   Web of Science ®Google Scholar
• Su, X., Tsai, C.-L., Wang, H., Nickerson, D. M., and Li, B. (2009), “Subgroup Analysis via Recursive Partitioning,” Journal of Machine Learning Research, 10, 141–158.
   Web of Science ®Google Scholar
• Xu, Y., Yu, M., Zhao, Y.-Q., Li, Q., Wang, S., and Shao, J. (2015), “Regularized Outcome Weighted Subgroup Identification for Differential Treatment Effects,” Biometrics, 71, 645–653.
   PubMed Web of Science ®Google Scholar
• Zhang, B., Tsiatis, A. A., Davidian, M., Zhang, M., and Laber, E. (2012a), “Estimating Optimal Treatment Regimes From a Classification Perspective,” Stat, 1, 103–114.
   PubMedGoogle Scholar
• Zhang, B., Tsiatis, A. A., Laber, E. B., and Davidian, M. (2012b), “A Robust Method for Estimating Optimal Treatment Regimes,” Biometrics, 68, 1010–1018.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Laber, E. B., Tsiatis, A., and Davidian, M. (2015), “Using Decision Lists to Construct Interpretable and Parsimonious Treatment Regimes,” Biometrics, 71, 895–904.
   PubMed Web of Science ®Google Scholar
• Zhao, L., Tian, L., Cai, T., Claggett, B., and Wei, L.-J. (2013), “Effectively Selecting a Target Population for a Future Comparative Study,” Journal of the American Statistical Association, 108, 527–539.
   PubMed Web of Science ®Google Scholar
• Zhao, Y., Zeng, D., Rush, A. J., and Kosorok, M. R. (2012), “Estimating Individualized Treatment Rules Using Outcome Weighted Learning,” Journal of the American Statistical Association, 107, 1106–1118.
   PubMed Web of Science ®Google Scholar